Cleared Traditional

K220430 - Capsulo

K220430 is the FDA 510(k) clearance for Capsulo by Quantel Medical. It is a Class 2 Ophthalmic device (product code HQF) cleared through the Traditional 510(k) pathway after a 86-day FDA review.

K220430 · Quantel Medical · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2022
Decision
86d
Days
Class 2
Risk

K220430 is an FDA 510(k) clearance for the Capsulo. Classified as Laser, Ophthalmic (product code HQF), Class II - Special Controls.

Submitted by Quantel Medical (Cournon D'Auvergne-Cedex, FR). The FDA issued a Cleared decision on May 12, 2022 after a review of 86 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4390 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Quantel Medical devices

Submission Details

510(k) Number K220430 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 15, 2022
Decision Date May 12, 2022
Days to Decision 86 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 110d · This submission: 86d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HQF Laser, Ophthalmic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4390
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Consultant

O'Connell Regulatory Consultants, Inc.
Maureen O'Connell

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - HQF Laser, Ophthalmic

All 63
Devices cleared under the same product code (HQF) and FDA review panel - the closest regulatory comparables to K220430.
Tango Neo, Tango Reflex Neo, Ultra Q Reflex Neo
K222395 · Ellex Medical Pty, Ltd. · Nov 2022
ECHO Photocoagulator
K222157 · Norlase · Oct 2022
Selecta Duet LED, Digital Duet, Selecta LED Trio, Digital Trio Laser Systems
K220877 · Lumenis Be, Inc. · Jul 2022
Iridex 810 Laser
K213592 · Iridex Corporation · Mar 2022
Tango, Tango Reflex, Ultra Q, Ultra Q Reflex, Solo
K212630 · Ellex Medical Pty, Ltd. · Dec 2021
Ophthalmic Yag Laser System YC-200
K203130 · Nidek Co., Ltd. · Dec 2020